Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project

INTRODUCTION: Randomized clinical trials showed that bortezomib, in addition to conventional chemotherapy, improves survival and disease progression in multiple myeloma (MM) patients not eligible for stem cell transplantation. The aim of this retrospective population-based cohort study is the evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Franchi, Matteo, Vener, Claudia, Garau, Donatella, Kirchmayer, Ursula, Di Martino, Mirko, Romero, Marilena, De Carlo, Ilenia, Scondotto, Salvatore, Stival, Chiara, Della Porta, Matteo Giovanni, Passamonti, Francesco, Corrao, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905486/
https://www.ncbi.nlm.nih.gov/pubmed/33747423
http://dx.doi.org/10.1177/2040620721996488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905486/
https://www.ncbi.nlm.nih.gov/pubmed/33747423
http://dx.doi.org/10.1177/2040620721996488

Ejemplares similares